These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6292428)

  • 1. Purification and characterisation of a fimbrial haemagglutinin from Bordetella pertussis for use in an enzyme-linked immunosorbent assay.
    Askelöf P; Granström M; Gillenius P; Lindberg AA
    J Med Microbiol; 1982 Feb; 15(1):73-83. PubMed ID: 6292428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of antibodies in human serum against the fimbrial haemagglutinin of Bordetella pertussis by enzyme-linked immunosorbent assay.
    Granström M; Lindberg AA; Askelöf P; Hederstedt B
    J Med Microbiol; 1982 Feb; 15(1):85-96. PubMed ID: 6292429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serologic diagnosis of whooping cough by an enzyme-linked immunosorbent assay using fimbrial hemagglutinin as antigen.
    Granström M; Granström G; Lindfors A; Askelöf P
    J Infect Dis; 1982 Dec; 146(6):741-5. PubMed ID: 6128367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific anti-Bordetella pertussis activities in human blood examined by enzyme-linked immunoassay and biological assay.
    Marley PB; Wilson JV; Habel H; Blaskett A
    Dev Biol Stand; 1985; 61():341-52. PubMed ID: 2872123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and partial characterization of filamentous haemagglutinin from Bordetella pertussis using monoclonal antibodies.
    Selmer JC; Larsen FS; Hertz JB; Parton R
    Acta Pathol Microbiol Immunol Scand C; 1984 Oct; 92(5):279-84. PubMed ID: 6097092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen.
    Zhang JM; Cowell JL; Steven AC; Manclark CR
    Dev Biol Stand; 1985; 61():173-85. PubMed ID: 2872103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis.
    Pittman M
    Rev Infect Dis; 1979; 1(3):401-12. PubMed ID: 233166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
    Winsnes R; Lønnes T; Møgster B; Berdal BP
    Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum.
    Healy CM; Munoz FM; Rench MA; Halasa NB; Edwards KM; Baker CJ
    J Infect Dis; 2004 Jul; 190(2):335-40. PubMed ID: 15216470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serologic diagnosis of whooping cough by enzyme-linked immunosorbent assay.
    Conway SP; Balfour AH; Ross H
    Pediatr Infect Dis J; 1988 Aug; 7(8):570-4. PubMed ID: 2902556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class-specific antibody response to lymphocytosis promoting factor (LPF) and fimbriae (F) in pertussis.
    Viljanen MK; Mertsola J; Kuronen T; Ruuskanen O
    Dev Biol Stand; 1985; 61():337-40. PubMed ID: 2872122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of the lymphocytosis promoting factor-haemagglutinin of Bordetella pertussis by affinity chromatography.
    Irons LI; MacLennan AP
    Biochim Biophys Acta; 1979 Sep; 580(1):175-85. PubMed ID: 232665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and crystallization of fimbrial hemagglutinin from Bordetella pertussis.
    Arai H; Munoz JJ
    Infect Immun; 1979 Jul; 25(1):460-2. PubMed ID: 39033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4-24 years in Turkey.
    Cevik M; Beyazova U; Aral AL; Duyan Camurdan A; Ozkan S; Sahin F; Aybay C
    Clin Microbiol Infect; 2008 Apr; 14(4):388-90. PubMed ID: 18190581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whooping cough antibody.
    Lau R
    N Z Med J; 1989 Mar; 102(863):113. PubMed ID: 2538785
    [No Abstract]   [Full Text] [Related]  

  • 16. Release and purification of fimbriae from Bordetella pertussis.
    Irons LI; Ashworth LA; Robinson A
    Dev Biol Stand; 1985; 61():153-63. PubMed ID: 2872101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological responses to infection with B. pertussis.
    Giammanco A; Taormina S; Genovese M; Mangiaracina G; Giammanco G; Chiarini A
    Dev Biol Stand; 1997; 89():213-20. PubMed ID: 9272353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum IgA antibody to Bordetella pertussis as an indicator of infection.
    Nagel J; Poot-Scholtens EJ
    J Med Microbiol; 1983 Nov; 16(4):417-26. PubMed ID: 6315942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussis.
    Trollfors B; Lagergård T; Taranger J; Bergfors E; Schneerson R; Robbins JB
    Clin Diagn Lab Immunol; 2001 Sep; 8(5):1015-7. PubMed ID: 11527820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pertussis (whooping cough) toxin and Bordetella pertussis whole-cell antibody levels in a healthy New Zealand population.
    Lau RC
    N Z Med J; 1989 Oct; 102(878):560-2. PubMed ID: 2554227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.